RSSS — Research Solutions Balance Sheet
0.000.00%
- $84.90m
- $80.68m
- $37.70m
- 51
- 34
- 67
- 49
Annual balance sheet for Research Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.35 | 9.31 | 11 | 10.6 | 13.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.49 | 4.45 | 4.72 | 5.25 | 6.15 |
Prepaid Expenses | |||||
Total Current Assets | 10.2 | 14.7 | 16.9 | 17 | 21.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.229 | 0.084 | 0.021 | 0.048 | 0.07 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 10.4 | 14.8 | 16.9 | 17 | 21.8 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.3 | 9.95 | 11.5 | 12.1 | 14.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.38 | 9.95 | 11.5 | 12.1 | 14.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3.03 | 4.86 | 5.43 | 4.88 | 7.33 |
Total Liabilities & Shareholders' Equity | 10.4 | 14.8 | 16.9 | 17 | 21.8 |
Total Common Shares Outstanding |